Ana M. Real-Lopez

Albacete, CM, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Corrigendum: Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.

Corrigendum: Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.

Journal: Frontiers in immunology

Published: November 26, 2024

Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.

Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.

Journal: Frontiers in immunology

Published: August 14, 2024

Perceived illness-related uncertainty among patients with mid-stage relapsing-remitting multiple sclerosis.

Perceived illness-related uncertainty among patients with mid-stage relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: February 14, 2024

Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis.

Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis.

Journal: Patient preference and adherence

Published: January 12, 2024

Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale.

Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: January 03, 2024

Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study.

Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study.

Journal: Multiple sclerosis and related disorders

Published: September 19, 2023

Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.

Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.

Journal: Neurology and therapy

Published: May 29, 2023

Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohort.

Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohort.

Journal: Multiple sclerosis and related disorders

Published: November 23, 2022

Multiple sclerosis and fatigue. It is necessary to improve

Multiple sclerosis and fatigue. It is necessary to improve

Journal: Rehabilitacion

Published: April 25, 2022

Effectiveness of Dimethyl Fumarate in Real-World Clinical Practice and Strategy to Minimize Adverse Effects and Use of Healthcare Resources.

Effectiveness of Dimethyl Fumarate in Real-World Clinical Practice and Strategy to Minimize Adverse Effects and Use of Healthcare Resources.

Journal: Patient preference and adherence

Published: October 08, 2020

Long-term effectiveness of glatiramer acetate in clinical practice conditions.

Long-term effectiveness of glatiramer acetate in clinical practice conditions.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

Published: December 17, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026